Literature DB >> 1791199

Lung mast cells in plexogenic pulmonary arteriopathy.

D Heath1, M Yacoub.   

Abstract

The numbers of mast cells/mm2 of lung parenchyma were counted in four controls, 15 cases of primary plexogenic pulmonary arteriopathy (PPA), and 17 cases in which the arteriopathy was secondary to congenital heart disease, to determine if increased numbers occur in PPA and with what stage of disease they might be associated. Considerable accumulations of lung mast cells may occur in this disease, but these are not closely related to any particular histological stage in the development of the arteriopathy. It is postulated that while mast cells could conceivably exert a vasodilatory effect on constricted small pulmonary arteries, it seems more likely that they are part of the parenchymal changes that commonly develop in this disease.

Entities:  

Mesh:

Year:  1991        PMID: 1791199      PMCID: PMC494968          DOI: 10.1136/jcp.44.12.1003

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Staining of sulphated mucopolysaccharides.

Authors:  I D HEATH
Journal:  Nature       Date:  1961-09-30       Impact factor: 49.962

2.  Histological changes in the lung in diseases associated with pulmonary venous hypertension.

Authors:  D HEATH; J E EDWARDS
Journal:  Br J Dis Chest       Date:  1959-01

3.  The histopathology of 36 cases of plexogenic pulmonary arteriopathy.

Authors:  A W Caslin; D Heath; B Madden; M Yacoub; J R Gosney; P Smith
Journal:  Histopathology       Date:  1990-01       Impact factor: 5.087

4.  The mast cells of the human uterus.

Authors:  J Crow; L More; S Howe
Journal:  APMIS       Date:  1988-10       Impact factor: 3.205

5.  Role of histamine in hypoxic pulmonary hypertension in the rat. I. Blockade or potentiation of endogenous amines, kinins, and ATP.

Authors:  A Hauge
Journal:  Circ Res       Date:  1968-03       Impact factor: 17.367

6.  Lung mast cell hyperplasia and pulmonary histamine-forming capacity in hypoxic rats.

Authors:  J M Kay; J C Waymire; R F Grover
Journal:  Am J Physiol       Date:  1974-01

7.  Pulmonary mast cells in mitral stenosis.

Authors:  D Heath; T Trueman; P Sukonthamarn
Journal:  Cardiovasc Res       Date:  1969-10       Impact factor: 10.787

8.  Mucosal mast cells of the rat intestine: a re-evaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycan.

Authors:  U Wingren; L Enerbäck
Journal:  Histochem J       Date:  1983-06

9.  Pulmonary mast cells in cattle and ilamas at high altitude.

Authors:  A Williams; D Heath; P Harris; D Williams; P Smith
Journal:  J Pathol       Date:  1981-05       Impact factor: 7.996

10.  Pulmonary endocrine cells in hypertensive pulmonary vascular disease.

Authors:  D Heath; M Yacoub; J R Gosney; B Madden; A W Caslin; P Smith
Journal:  Histopathology       Date:  1990-01       Impact factor: 5.087

View more
  26 in total

1.  Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  Shuxin Liang; Ankit A Desai; Stephen M Black; Haiyang Tang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension.

Authors:  Rajkumar Savai; Hamza M Al-Tamari; Daniel Sedding; Baktybek Kojonazarov; Christian Muecke; Rebecca Teske; Mario R Capecchi; Norbert Weissmann; Friedrich Grimminger; Werner Seeger; Ralph Theo Schermuly; Soni Savai Pullamsetti
Journal:  Nat Med       Date:  2014-10-26       Impact factor: 53.440

Review 3.  Pulmonary arterial hypertension: pathogenesis and clinical management.

Authors:  Thenappan Thenappan; Mark L Ormiston; John J Ryan; Stephen L Archer
Journal:  BMJ       Date:  2018-03-14

4.  Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

Authors:  Shiro Mizuno; Laszlo Farkas; Aysar Al Husseini; Daniela Farkas; Jose Gomez-Arroyo; Donatas Kraskauskas; Mark R Nicolls; Carlyne D Cool; Herman J Bogaard; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2012-07-27       Impact factor: 6.914

5.  Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension.

Authors:  Silvia Ulrich; Mark R Nicolls; Laima Taraseviciene; Rudolf Speich; Norbert Voelkel
Journal:  Respiration       Date:  2007-11-20       Impact factor: 3.580

6.  Arachnoid nodules in the lungs of high altitude Indians.

Authors:  D Heath; D Williams
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

7.  Mast cells in the human lung at high altitude.

Authors:  D Heath
Journal:  Int J Biometeorol       Date:  1992-10       Impact factor: 3.787

8.  Histological characterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease.

Authors:  Djuro Kosanovic; Bhola Kumar Dahal; Dorothea Maren Peters; Michael Seimetz; Malgorzata Wygrecka; Katrin Hoffmann; Jochen Antel; Irwin Reiss; Hossein Ardeschir Ghofrani; Norbert Weissmann; Friedrich Grimminger; Werner Seeger; Ralph Theo Schermuly
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

Review 9.  Mast cells: an expanding pathophysiological role from allergy to other disorders.

Authors:  Preet Anand; Baldev Singh; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-06       Impact factor: 3.000

10.  Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.

Authors:  Laimute Taraseviciene-Stewart; Mark R Nicolls; Donatas Kraskauskas; Robertas Scerbavicius; Nana Burns; Carlyne Cool; Kathy Wood; Jane E Parr; Susan A Boackle; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2007-04-05       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.